Cargando…
IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS
CBA mice were rendered highly tolerant to A/Jax cells by neonatal intravenous injections of (CBA x A)F(1) spleen cells. The high degree of tolerance was ascertained by the absence of circulating antibodies detected in the sera by the usual tests and by the perfect state of A skin grafts during all t...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1972
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138981/ https://www.ncbi.nlm.nih.gov/pubmed/4623319 |
_version_ | 1782143689882075136 |
---|---|
author | Voisin, G. A. Kinsky, R. G. Duc, H. T. |
author_facet | Voisin, G. A. Kinsky, R. G. Duc, H. T. |
author_sort | Voisin, G. A. |
collection | PubMed |
description | CBA mice were rendered highly tolerant to A/Jax cells by neonatal intravenous injections of (CBA x A)F(1) spleen cells. The high degree of tolerance was ascertained by the absence of circulating antibodies detected in the sera by the usual tests and by the perfect state of A skin grafts during all the experiments. Tolerant sera (sera from tolerant animals) were studied at three periods of tolerance: before skin test grafting, from 2 to 11 wk after grafting, and at time of sacrifice at almost 6 months of age. The tolerant sera were shown to have specific facilitation-enhancing properties promoting the take and growth of A/Jax sarcoma (SaI and /Sa 15091a grafted on normal CBA mice. These properties were present throughout the duration of the experiments, showing that they were not the result of a beginning interruption of tolerance. The tolerant sera, although lacking the usual serological properties (hemagglutination, hemolysis, cytotoxicity, passive cutaneous anaphylaxis) had, however, specific synergistic hemagglutinating properties (increasing the hemagglutinating titer of a reference immune serum). Antibodies giving direct specific hemagglutination could be extracted from spleens of 20% of highly tolerant mice. The tolerant sera were also found to contain more IgG1 and more IgA than normal sera while they contained normal quantities of the complement-fixing immunoglobulins IgG2 and IgM. Fractionation of tolerant sera on DEAE chromatography column confirmed the data concerning immunoglobulin classes and demonstrated direct specific serological activities undetected in unfractionated sera: a weak hemolysis in the most cationic fractions and a weak hemagglutination in the middle fractions. Synergistic hemagglutination, detected in unfractionated serum, was localized in fast anionic fractions containing high IgA concentration, along with facilitation-enhancing activity, thus confirming a link suggested previously between these three properties. The relation between immunological tolerance and facilitating antibodies was discussed in the light of the fact that antibodies, possibly of a particular class continuously present at low dose in the sera of highly tolerant animals, are able to transfer (at least partly) this state of tolerance provided a sensitive test system is utilized. |
format | Text |
id | pubmed-2138981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1972 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21389812008-04-17 IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS Voisin, G. A. Kinsky, R. G. Duc, H. T. J Exp Med Article CBA mice were rendered highly tolerant to A/Jax cells by neonatal intravenous injections of (CBA x A)F(1) spleen cells. The high degree of tolerance was ascertained by the absence of circulating antibodies detected in the sera by the usual tests and by the perfect state of A skin grafts during all the experiments. Tolerant sera (sera from tolerant animals) were studied at three periods of tolerance: before skin test grafting, from 2 to 11 wk after grafting, and at time of sacrifice at almost 6 months of age. The tolerant sera were shown to have specific facilitation-enhancing properties promoting the take and growth of A/Jax sarcoma (SaI and /Sa 15091a grafted on normal CBA mice. These properties were present throughout the duration of the experiments, showing that they were not the result of a beginning interruption of tolerance. The tolerant sera, although lacking the usual serological properties (hemagglutination, hemolysis, cytotoxicity, passive cutaneous anaphylaxis) had, however, specific synergistic hemagglutinating properties (increasing the hemagglutinating titer of a reference immune serum). Antibodies giving direct specific hemagglutination could be extracted from spleens of 20% of highly tolerant mice. The tolerant sera were also found to contain more IgG1 and more IgA than normal sera while they contained normal quantities of the complement-fixing immunoglobulins IgG2 and IgM. Fractionation of tolerant sera on DEAE chromatography column confirmed the data concerning immunoglobulin classes and demonstrated direct specific serological activities undetected in unfractionated sera: a weak hemolysis in the most cationic fractions and a weak hemagglutination in the middle fractions. Synergistic hemagglutination, detected in unfractionated serum, was localized in fast anionic fractions containing high IgA concentration, along with facilitation-enhancing activity, thus confirming a link suggested previously between these three properties. The relation between immunological tolerance and facilitating antibodies was discussed in the light of the fact that antibodies, possibly of a particular class continuously present at low dose in the sera of highly tolerant animals, are able to transfer (at least partly) this state of tolerance provided a sensitive test system is utilized. The Rockefeller University Press 1972-05-01 /pmc/articles/PMC2138981/ /pubmed/4623319 Text en Copyright © 1972 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Voisin, G. A. Kinsky, R. G. Duc, H. T. IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title | IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title_full | IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title_fullStr | IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title_full_unstemmed | IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title_short | IMMUNE STATUS OF MICE TOLERANT OF LIVING CELLS : II. CONTINUOUS PRESENCE AND NATURE OF FACILITATION-ENHANCING ANTIBODIES IN TOLERANT ANIMALS |
title_sort | immune status of mice tolerant of living cells : ii. continuous presence and nature of facilitation-enhancing antibodies in tolerant animals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138981/ https://www.ncbi.nlm.nih.gov/pubmed/4623319 |
work_keys_str_mv | AT voisinga immunestatusofmicetolerantoflivingcellsiicontinuouspresenceandnatureoffacilitationenhancingantibodiesintolerantanimals AT kinskyrg immunestatusofmicetolerantoflivingcellsiicontinuouspresenceandnatureoffacilitationenhancingantibodiesintolerantanimals AT ducht immunestatusofmicetolerantoflivingcellsiicontinuouspresenceandnatureoffacilitationenhancingantibodiesintolerantanimals |